148 related articles for article (PubMed ID: 20421454)
1. Senescence induction in human fibroblasts and hematopoietic progenitors by leukemogenic fusion proteins.
Wajapeyee N; Wang SZ; Serra RW; Solomon PD; Nagarajan A; Zhu X; Green MR
Blood; 2010 Jun; 115(24):5057-60. PubMed ID: 20421454
[TBL] [Abstract][Full Text] [Related]
2. RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.
Wolyniec K; Wotton S; Kilbey A; Jenkins A; Terry A; Peters G; Stocking C; Cameron E; Neil JC
Oncogene; 2009 Jul; 28(27):2502-12. PubMed ID: 19448675
[TBL] [Abstract][Full Text] [Related]
3. RUNX-mediated growth arrest and senescence are attenuated by diverse mechanisms in cells expressing RUNX1 fusion oncoproteins.
Anderson G; Mackay N; Gilroy K; Hay J; Borland G; McDonald A; Bell M; Hassanudin SA; Cameron E; Neil JC; Kilbey A
J Cell Biochem; 2018 Mar; 119(3):2750-2762. PubMed ID: 29052866
[TBL] [Abstract][Full Text] [Related]
4. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.
Mulloy JC; Cammenga J; MacKenzie KL; Berguido FJ; Moore MA; Nimer SD
Blood; 2002 Jan; 99(1):15-23. PubMed ID: 11756147
[TBL] [Abstract][Full Text] [Related]
5. Wnt signaling induces transcription, spatial proximity, and translocation of fusion gene partners in human hematopoietic cells.
Ugarte GD; Vargas MF; Medina MA; León P; Necuñir D; Elorza AA; Gutiérrez SE; Moon RT; Loyola A; De Ferrari GV
Blood; 2015 Oct; 126(15):1785-9. PubMed ID: 26333776
[TBL] [Abstract][Full Text] [Related]
6. Cbfb/Runx1 repression-independent blockage of differentiation and accumulation of Csf2rb-expressing cells by Cbfb-MYH11.
Hyde RK; Kamikubo Y; Anderson S; Kirby M; Alemu L; Zhao L; Liu PP
Blood; 2010 Feb; 115(7):1433-43. PubMed ID: 20007544
[TBL] [Abstract][Full Text] [Related]
7. The utility of the multiplex reverse transcriptase-polymerase chain reaction assay in the detection of hematologic malignancies.
Kim MJ; Cho SY; Lee WI; Park TS; Lee HJ
Ann Lab Med; 2013 Jul; 33(4):304-7. PubMed ID: 23826571
[No Abstract] [Full Text] [Related]
8. Reciprocal t(9;22) ABL/BCR fusion proteins: leukemogenic potential and effects on B cell commitment.
Zheng X; Oancea C; Henschler R; Moore MA; Ruthardt M
PLoS One; 2009 Oct; 4(10):e7661. PubMed ID: 19876398
[TBL] [Abstract][Full Text] [Related]
9. Incidence of preleukemic fusion genes in healthy subjects.
Kosik P; Skorvaga M; Belyaev I
Neoplasma; 2016; 63(5):659-72. PubMed ID: 27468869
[TBL] [Abstract][Full Text] [Related]
10. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia.
Ma CC; Chai Y; Chen HL; Wang X; Gao Y; Hu WL; Xiang X
J Int Med Res; 2020 May; 48(5):300060520919237. PubMed ID: 32366154
[TBL] [Abstract][Full Text] [Related]
11. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
Bakshi R; Zaidi SK; Pande S; Hassan MQ; Young DW; Montecino M; Lian JB; van Wijnen AJ; Stein JL; Stein GS
J Cell Sci; 2008 Dec; 121(Pt 23):3981-90. PubMed ID: 19001502
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases.
Quackenbush RC; Reuther GW; Miller JP; Courtney KD; Pear WS; Pendergast AM
Blood; 2000 May; 95(9):2913-21. PubMed ID: 10779439
[TBL] [Abstract][Full Text] [Related]
13. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
[TBL] [Abstract][Full Text] [Related]
14. Cooperative and redundant effects of STAT5 and Ras signaling in BCR/ABL transformed hematopoietic cells.
Hoover RR; Gerlach MJ; Koh EY; Daley GQ
Oncogene; 2001 Sep; 20(41):5826-35. PubMed ID: 11593388
[TBL] [Abstract][Full Text] [Related]
15. AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1.
Nishida S; Hosen N; Shirakata T; Kanato K; Yanagihara M; Nakatsuka S; Hoshida Y; Nakazawa T; Harada Y; Tatsumi N; Tsuboi A; Kawakami M; Oka Y; Oji Y; Aozasa K; Kawase I; Sugiyama H
Blood; 2006 Apr; 107(8):3303-12. PubMed ID: 16380455
[TBL] [Abstract][Full Text] [Related]
16. Expression of RUNX1-JAK2 in Human Induced Pluripotent Stem Cell-Derived Hematopoietic Cells Activates the JAK-STAT and MYC Pathways.
Fortschegger K; Husa AM; Schinnerl D; Nebral K; Strehl S
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299194
[TBL] [Abstract][Full Text] [Related]
17. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation.
Bäsecke J; Schwieger M; Griesinger F; Schiedlmeier B; Wulf G; Trümper L; Stocking C
Leuk Lymphoma; 2005 Feb; 46(2):265-72. PubMed ID: 15621811
[TBL] [Abstract][Full Text] [Related]
18. Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice.
Cuenco GM; Ren R
Oncogene; 2004 Jan; 23(2):569-79. PubMed ID: 14724585
[TBL] [Abstract][Full Text] [Related]
19. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
[TBL] [Abstract][Full Text] [Related]
20. The role of fluorescence in situ hybridization (FISH) for monitoring hematologic malignancies with BCR/ABL or ETO/AML1 rearrangement: a comparative study with FISH and G-banding on 919 consecutive specimens of hematologic malignancies.
Lee DY; Cho HI; Kang YH; Yun SS; Park SY; Lee YS; Kim Y; Lee DS
Cancer Genet Cytogenet; 2004 Jul; 152(1):1-7. PubMed ID: 15193435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
